BRIEF-Agios Pharmaceuticals Says FDA Has Not Issued Decision On Agios' sNDA for Mitapivat

Reuters12-08
BRIEF-Agios Pharmaceuticals Says FDA Has Not Issued Decision On Agios' sNDA for Mitapivat

Dec 8 (Reuters) - Agios Pharmaceuticals Inc AGIO.O:

  • AGIOS PROVIDES UPDATE ON U.S. SNDA FOR MITAPIVAT IN THALASSEMIA

  • AGIOS PHARMACEUTICALS INC - FDA HAS NOT ISSUED DECISION ON AGIOS' SNDA FOR MITAPIVAT

  • AGIOS PHARMACEUTICALS INC - COLLABORATING WITH FDA ON LABELING AND REMS MATERIALS FOR FOR MITAPIVAT

  • AGIOS PHARMACEUTICALS INC - FDA HAS NOT REQUESTED NEW EFFICACY OR SAFETY DATA

  • AGIOS PHARMACEUTICALS INC - FDA HAS NOT PROVIDED TIMELINE FOR REGULATORY DECISION

Source text: ID:nGNX5KLcnS

Further company coverage: AGIO.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment